Sight Sciences, Inc. (SGHT)
8.34
-0.08
(-0.95%)
USD |
NASDAQ |
Sep 03, 16:00
8.34
0.00 (0.00%)
After-Hours: 20:00
Sight Sciences Net Income (Quarterly) : -4.446M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -4.446M |
| March 31, 2026 | -12.98M |
| December 31, 2025 | -4.162M |
| September 30, 2025 | -8.169M |
| June 30, 2025 | -11.94M |
| March 31, 2025 | -14.15M |
| December 31, 2024 | -11.85M |
| September 30, 2024 | -11.07M |
| June 30, 2024 | -12.33M |
| March 31, 2024 | -16.27M |
| December 31, 2023 | -10.69M |
| September 30, 2023 | -13.04M |
| June 30, 2023 | -14.75M |
| Date | Value |
|---|---|
| March 31, 2023 | -17.07M |
| December 31, 2022 | -16.91M |
| September 30, 2022 | -22.23M |
| June 30, 2022 | -23.84M |
| March 31, 2022 | -23.26M |
| December 31, 2021 | -15.94M |
| September 30, 2021 | -17.17M |
| June 30, 2021 | -17.62M |
| March 31, 2021 | -12.24M |
| December 31, 2020 | -9.105M |
| September 30, 2020 | -8.097M |
| June 30, 2020 | -8.316M |
| March 31, 2020 | -9.175M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Integra LifeSciences Holdings Corp. | 4.482M |
| Abbott Laboratories | 928.00M |
| AngioDynamics, Inc. | -11.40M |
| Alphatec Holdings, Inc. | -25.78M |
| AtriCure, Inc. | 8.955M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 23.39M |
| Total Expenses (Quarterly) | 27.83M |
| EPS Diluted (Quarterly) | -0.0816 |
| Enterprise Value | 422.93M |
| Gross Profit Margin (Quarterly) | 91.39% |
| Profit Margin (Quarterly) | -19.01% |
| Earnings Yield | -6.67% |
| Normalized Earnings Yield | -6.674 |